Clinical Trials Browser

Leukemia, Myeloid, Acute

NCT03969446 2026-03-05

Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory

Phase 1 Recruiting

54 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03896269 2026-02-20

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Phase 1 Recruiting

38 enrolled

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic

NCT05620017 2026-02-09

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

Phase 1 Recruiting

182 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06565689 2026-02-05

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

Phase 1 Recruiting

48 enrolled

Lymphoid

Recurrence, Lymphoma, B-Cell

NCT06574568 2026-02-05

A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma

Phase 1 Recruiting

70 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT06792552 2026-01-29

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Phase 1 Recruiting

414 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07369505 2026-01-27

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Phase 1 Recruiting

27 enrolled

EndocrineGastrointestinalGenitourinaryNET

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Tuberous Sclerosis, Neuroendocrine Tumors

NCT06997094 2026-01-26

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Phase 1 Recruiting

24 enrolled

Head & Neck

Human Papillomavirus-Negative Neck Squamous Cell Carcinoma

NCT07368478 2026-01-26

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

Phase 1 Recruiting

180 enrolled

Advanced Solid Malignancies

NCT07348211 2026-01-23

SIM0610-101

Phase 1 Recruiting

260 enrolled

GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT06298058 2026-01-07

A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.

Phase 1 Recruiting

144 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06482905 2026-01-06

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

Phase 1 Recruiting

52 enrolled

CNS

Glioma

NCT07252414 2026-01-05

GenSci143 in Participants With Advanced Solid Tumors

Phase 1 Recruiting

180 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06038058 2025-12-30

A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies

Phase 1 Recruiting

164 enrolled

Advanced Malignancies

NCT07251166 2025-12-24

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors

Phase 1 Recruiting

170 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07087197 2025-12-08

A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

Phase 1 Recruiting

90 enrolled

Other solid neoplasm

Metastatic Solid Tumors

NCT06428331 2025-12-05

A Study of SKB518 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

150 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06826040 2025-12-05

SKB445 for Injection in Solid Tumors

Phase 1 Recruiting

126 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07265921 2025-12-05

Solid Tumors

Phase 1 Recruiting

232 enrolled

Advanced Solid Cancer

NCT06238401 2025-11-24

An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

77 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06937957 2025-11-21

A Study of BR111 in Patients With Advanced Malignancies

Phase 1 Recruiting

166 enrolled

Advanced Malignancies

NCT05367635 2025-11-17

A Study of SKB315 in Patients With Advanced Solid Tumors

Phase 1 Recruiting

246 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07231081 2025-11-17

Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

Phase 1 Recruiting

85 enrolled

Other solid neoplasm

Solid Tumors

NCT07113925 2025-08-11

A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies

Phase 1 Recruiting

114 enrolled

Advanced Hematologic Malignancies

NCT04778839 2025-08-06

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Phase 1 Recruiting

98 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms

NCT06205849 2025-07-25

Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer

Phase 1 Recruiting

18 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07009457 2025-07-04

Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

Phase 1 Recruiting

48 enrolled

Thoracic

Widespread Small Cell Lung Cancer

NCT06132828 2025-07-03

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

216 enrolled

Other solid neoplasm

Solid Tumor

NCT07045454 2025-07-01

A Study of MHB118C Injection in Patients With Advanced Solid Tumors

Phase 1 Recruiting

200 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT06970795 2025-05-14

A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors

Phase 1 Recruiting

180 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT04998422 2025-03-13

A Study of HG381 Administered to Patients With Advanced Solid Tumors

Phase 1 Recruiting

57 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06683066 2024-11-12

Study on Human Bioequivalence of Triprerelin Acetate for Injection

Phase 1 Recruiting

120 enrolled

Genitourinary

Prostatic Neoplasms

NCT06550713 2024-08-13

A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies

Phase 1 Recruiting

100 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05877924 2024-03-26

A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.

Phase 1 Recruiting

200 enrolled

Advanced Malignant Tumors

NCT04965077 2024-03-13

Treatment of Advanced and Metastatic Solid Tumors With MIL97

Phase 1 Recruiting

62 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05877664 2024-03-06

Study of ZG0895.HCl in Patients With Advanced Solid Tumors

Phase 1 Recruiting

60 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06115902 2023-11-29

A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer

Phase 1 Recruiting

150 enrolled

Breast

Breast Neoplasms

NCT06056752 2023-10-24

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Phase 1 Recruiting

10 enrolled

Lymphoid

Burkitt Lymphoma

NCT05631886 2023-08-28

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Phase 1 Recruiting

10 enrolled

Lymphoid

Lymphoma, Neoplasm Metastasis, Recurrence

Clinical Trials

Tazemetostat and Palbociclib With CPX-351for R/R AML

Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

SIM0610-101

A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

GenSci143 in Participants With Advanced Solid Tumors

A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors

A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

A Study of SKB518 in Patients With Advanced Solid Tumors

SKB445 for Injection in Solid Tumors

Solid Tumors

An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors

A Study of BR111 in Patients With Advanced Malignancies

A Study of SKB315 in Patients With Advanced Solid Tumors

Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer

Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

A Study of MHB118C Injection in Patients With Advanced Solid Tumors

A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors

A Study of HG381 Administered to Patients With Advanced Solid Tumors

Study on Human Bioequivalence of Triprerelin Acetate for Injection

A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies

A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.

Treatment of Advanced and Metastatic Solid Tumors With MIL97

Study of ZG0895.HCl in Patients With Advanced Solid Tumors

A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors